- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Dynamic shifts management, Assif replaces Laskey at helm
Dynamic Healthcare Technologies is one of the many health IT companies shuffling top management in an effort to compensate for tougher market conditions. Mitch Laskey, who founded Dynamic and has served as its president and CEO, has stepped
Dynamic Healthcare Technologies is one of the many health IT companies shuffling top management in an effort to compensate for tougher market conditions. Mitch Laskey, who founded Dynamic and has served as its president and CEO, has stepped aside to become a consultant to the company. Christopher Assif, formerly president of Dynamic's Internet Solutions group, has replaced Laskey as CEO. John Fingado, formerly vice president and general manager of CoPath, has been appointed president and COO. Dynamic will concentrate its marketing on the CoMed product suite, which offers clinical connectivity and ASP-based products for laboratory, pathology, and radiology departments.
In related news, Dynamic has expanded the size of its board to seven members from five. Assif and Christopher Cooper, president of Plangent Systems and cofounder of Collaborative Medical Systems (a company acquired by Dynamic in 1996), are the newest appointees. Laskey has retained his seat on the board of directors.
© 2000 Miller Freeman Inc.
11/29/00, Issue # 117, page 3.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
